Research graph
References from Corrigendum to “Tumor-derived KLK5 activates TMEM158+ cancer-associated fibroblasts to induce CD8+ T cell exhaustion and confer resistance to cancer immunotherapy” [Drug Resist. Updates, Vol. 90, January 2027, 101473]. Local targets link to admitted publications; unresolved targets remain external evidence.
